Compositions and methods relating to resveratrol
AssigneeWilmore Labs L.L.C
InventorOtis L. Blanchard
Life of this patent
Estimating the term…
Abstract
The present invention relates to compositions and methods comprising resveratrol and uses thereof. Some embodiments include compositions and methods with increased bioavailability of resveratrol. Certain embodiments include compositions comprising resveratrol and a solubilizer. Particular embodiments include transmucosal delivery of resveratrol from the composition.
Claims25
A pharmaceutical composition in lozenge form consisting essentially of resveratrol and a solubilizer, wherein the solubilizer is selected from the group consisting of ribose and deoxyribose, wherein said pharmaceutical composition provides improved serum resveratrol bioavailability in a human subject upon administration compared to serum resveratrol bioavailability in a human subject upon administration of a pharmaceutical composition consisting essentially of resveratrol.
A pharmaceutical composition in lozenge form consisting essentially of resveratrol, a solubilizer, and a pharmaceutically acceptable carrier, wherein the solubilizer is selected from the group consisting of ribose and deoxyribose, wherein said pharmaceutical composition provides improved serum resveratrol bioavailability in a human subject upon administration compared to serum resveratrol bioavailability in a human subject upon administration of a pharmaceutical composition consisting essentially of resveratrol.
A pharmaceutical composition in lozenge form consisting essentially of resveratrol, a solubilizer, and a pH adjusting substance, wherein the solubilizer is selected from the group consisting of ribose and deoxyribose, wherein said pharmaceutical composition provides improved serum resveratrol bioavailability in a human subject upon administration compared to serum resveratrol bioavailability in a human subject upon administration of a pharmaceutical composition consisting essentially of resveratrol.
A pharmaceutical composition in lozenge form consisting essentially of resveratrol, a solubilizer, and a binder, wherein the solubilizer is selected from the group consisting of ribose and deoxyribose, wherein said pharmaceutical composition provides improved serum resveratrol bioavailability in a human subject upon administration compared to serum resveratrol bioavailability in a human subject upon administration of a pharmaceutical composition consisting essentially of resveratrol.
The pharmaceutical composition of claim1, further comprising flavorings.
A pharmaceutical composition in lozenge form consisting essentially of resveratrol, a solubilizer, and a penetration enhancer, wherein the solubilizer is selected from the group consisting of ribose and deoxyribose, wherein said pharmaceutical composition provides improved serum resveratrol bioavailability in a human subject upon administration compared to serum resveratrol bioavailability in a human subject upon administration of a pharmaceutical composition consisting essentially of resveratrol.
A pharmaceutical composition in a solid or semi-solid lozenge form consisting essentially of resveratrol and a solubilizer, wherein the solubilizer is selected from the group consisting of ribose and deoxyribose, wherein said pharmaceutical composition provides improved serum resveratrol bioavailability in a human subject upon administration compared to serum resveratrol bioavailability in a human subject upon administration of a pharmaceutical composition consisting essentially of resveratrol.
Dependencies are inferred from the claim text.